Financial Performance - In 2024, the company achieved a revenue of 4.709 billion CNY, a year-on-year increase of 14.77% [1] - The net profit attributable to shareholders was 114 million CNY, with seed sales and volumes steadily increasing [1] - In Q1 2025, revenue reached 835 million CNY, up 24.13% compared to the same period last year, with a net profit of 2.197 million CNY [1] Rice Business - Rice seed sales revenue was 1.858 billion CNY, a growth of 5.67% [2] - The company operates in 17 provinces, establishing a comprehensive sales network [2] - A patented method for hybrid rice seed production has been authorized, enhancing production efficiency and reducing costs [2] Corn Business - Corn seed sales revenue reached 589 million CNY, with a year-on-year growth of 20.43% and a gross margin of 33.15% [3] - The company has developed 19 hybrid corn varieties approved at the national level and 13 at the provincial level [3] - The company aims to rank among the top three in corn seed sales by the end of the 14th Five-Year Plan [3] International Market Development - In 2024, overseas sales of various agricultural seeds reached 19.3735 million kg, a 74.80% increase year-on-year, generating 492 million CNY in revenue, up 72.39% [4] - The company has successfully registered 24 hybrid rice and corn varieties in Southeast Asia and Africa [4] - International breeding collaborations are being pursued to enhance global competitiveness [4] Audit Opinions - The company believes the book value of receivables from liquor grain sales is accurate, and the methods for revenue recognition and bad debt provision are reasonable [5] - Measures will be taken to recover receivables within the next two years [5] - Strategies are in place to ensure the sale of corn seed inventory over the next two years [5]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of RMB 11.34 [7][8]. Core Views - The company experienced a revenue decline of 7.13% year-on-year in 2024, with total revenue of RMB 8.566 billion and a net profit attributable to shareholders of RMB 1.14 billion, down 43.08% year-on-year. The first quarter of 2025 saw a significant revenue drop of 32% year-on-year, resulting in a net loss of RMB 0.02 billion [1][2][3]. - Despite the current challenges, the company is expected to benefit from a rebound in domestic corn prices due to supply-demand imbalances and its strong research and development capabilities, particularly in transgenic corn [3][4]. Summary by Sections Financial Performance - In 2024, the company reported revenue of RMB 50 billion from corn seeds, down 17% year-on-year, with a gross margin of 34.6%, a decrease of 5.4 percentage points. In contrast, hybrid rice revenue was RMB 20 billion, up 13% year-on-year, with a gross margin of 37.6%, an increase of 1.23 percentage points [2]. - The first quarter of 2025 showed a revenue of RMB 14.1 billion, a 32% decline year-on-year, and a net profit of -RMB 0.02 billion, indicating a shift to loss compared to the previous year [1][3]. Profit Forecast and Valuation - The profit forecast for 2025 and 2026 has been adjusted downwards due to intense competition in corn seed varieties. The expected net profits for 2025 and 2026 are RMB 2.1 billion and RMB 4.3 billion, respectively, down from previous estimates of RMB 9.0 billion and RMB 12.0 billion [4][6]. - The report estimates a target price of RMB 11.34 based on a price-to-book ratio of 3.0 times for 2025, reflecting the company's strong R&D advantages and market position [4][8].

证券简称： 康农种业 证券代码： 837403 湖北省宜昌市长阳经济开发区长阳大道 553 号 湖北康农种业股份有限公司 湖北康农种业股份有限公司招股说明书（申报稿） 本公司的发行申请尚未经中国证监会注册。本招股说明书申报稿不具有据以发行股票的法律效 力，投资者应当以正式公告的招股说明书全文作为投资决定的依据。 本次股票发行后拟在北京证券交易所上市，该市场具有较高的投资风险。北京证券交易所主要 服务创新型中小企业，上市公司具有经营风险高、业绩不稳定、退市风险高等特点，投资者面临较 大的市场风险。投资者应充分了解北京证券交易所市场的投资风险及本公司所披露的风险因素，审 慎作出投资决定。 保荐机构（主承销商） （北京市西城区武定侯街 6 号卓著中心 10 层） 二零二三年九月 中国证监会和北京证券交易所对本次发行所作的任何决定或意见，均不表明其对注册申 请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其对发行人的盈利能力、 投资价值或者对投资者的收益作出实质性判断或者保证。任何与之相反的声明均属虚假不实 陈述。 根据《证券法》的规定，股票依法发行后，发行人经营与收益的变化，由发行人自行负 责；投资者自 ...

湖北省宜昌市长阳经济开发区长阳大道 553 号 湖北康农种业股份有限公司 湖北康农种业股份有限公司招股说明书（申报稿） 本公司的发行申请尚未经中国证监会注册。本招股说明书申报稿不具有据以发行股票的法律效 力，投资者应当以正式公告的招股说明书全文作为投资决定的依据。 本次股票发行后拟在北京证券交易所上市，该市场具有较高的投资风险。北京证券交易所主要 服务创新型中小企业，上市公司具有经营风险高、业绩不稳定、退市风险高等特点，投资者面临较 大的市场风险。投资者应充分了解北京证券交易所市场的投资风险及本公司所披露的风险因素，审 慎作出投资决定。 保荐机构（主承销商） （北京市西城区武定侯街 6 号卓著中心 10 层） 二零二三年四月 证券简称： 康农种业 证券代码： 837403 中国证监会和北京证券交易所对本次发行所作的任何决定或意见，均不表明其对注册申 请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其对发行人的盈利能力、 投资价值或者对投资者的收益作出实质性判断或者保证。任何与之相反的声明均属虚假不实 陈述。 根据《证券法》的规定，股票依法发行后，发行人经营与收益的变化，由发行人自行负 责；投资者自 ...